Development of an Oral Salmonella-Based Vaccine Platform against SARS-CoV-2.
Ontology highlight
ABSTRACT: Effective vaccine development for global outbreaks, such as the coronavirus disease 2019 (COVID-19), has been successful in the short run. However, the currently available vaccines have been associated with a higher frequency of adverse effects compared with other general vaccines. In this study, the possibility of an oral bacteria-based vaccine that can be safely used as a platform for large-scale, long-term immunization was evaluated. A well-known Salmonella strain that was previously considered as a vaccine delivery candidate was used. Recombinant Salmonella cells expressing engineered viral proteins related with COVID-19 pathogenesis were engineered, and the formulation of the oral vaccine candidate strain was evaluated by in vitro and in vivo experiments. First, engineer
SUBMITTER: Yoon W
PROVIDER: S-EPMC8777945 | biostudies-literature | 2022 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA